Cati-an, Apolinaria A.
HRN: 13-96-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2026
CO-AMOXICLAV 625MG (TAB)
04/12/2026
04/19/2026
PO
625mg
TID
CAP-LR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: